Nanotech Investing Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel , an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
Nanotech Investing Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
Nanotech Investing Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma
Nanotech Investing Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference
Nanotech Investing Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
CHARBONE annonce la nomination de Patrick Cuddihy au poste de Vice-president principal - Affaires strategiques
NevGold Announces Up to 85% Antimony Recovery From Positive Phase II Metallurgical Testwork at Oxide Gold-Antimony Limo Butte Project in Nevada
